Udg Healthcare PLC (LON:UDG) had its price target raised by equities research analysts at Jefferies Group LLC from GBX 785 ($10.22) to GBX 830 ($10.81) in a report released on Thursday. The brokerage currently has a “hold” rating on the stock. Jefferies Group LLC’s price target points to a potential downside of 0.12% from the stock’s current price.

A number of other brokerages have also recently commented on UDG. Berenberg Bank boosted their price target on Udg Healthcare PLC from GBX 745 ($9.70) to GBX 800 ($10.42) and gave the stock a “hold” rating in a research report on Friday, June 23rd. Liberum Capital reissued a “buy” rating and issued a GBX 930 ($12.11) price target on shares of Udg Healthcare PLC in a research report on Monday, June 19th. Stifel Nicolaus reissued a “hold” rating and issued a GBX 775 ($10.09) price target on shares of Udg Healthcare PLC in a research report on Thursday, August 3rd. Numis Securities Ltd reissued a “hold” rating and issued a GBX 730 ($9.51) price target on shares of Udg Healthcare PLC in a research report on Thursday, August 3rd. Finally, N+1 Singer reissued a “hold” rating on shares of Udg Healthcare PLC in a research report on Thursday, August 3rd. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of GBX 807.29 ($10.51).

Udg Healthcare PLC (LON UDG) opened at 835.00 on Thursday. Udg Healthcare PLC has a one year low of GBX 590.00 and a one year high of GBX 886.50. The firm has a 50-day moving average price of GBX 846.66 and a 200-day moving average price of GBX 757.97. The firm’s market cap is GBX 2.07 billion.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/udg-healthcare-plc-udg-price-target-raised-to-gbx-830/1466837.html.

In related news, insider Jez Moulding purchased 18,000 shares of the company’s stock in a transaction dated Wednesday, May 31st. The shares were purchased at an average cost of GBX 808 ($10.52) per share, with a total value of £145,440 ($189,399.66). Also, insider Chris Corbin sold 100,000 shares of the business’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of GBX 813 ($10.59), for a total value of £813,000 ($1,058,731.61).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.